Thermo Fisher Scientific debuts the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide...
Promega Corporation has launched its OncoMate MSI Dx Analysis System in vitro diagnostic (IVD) in the U.S., giving oncologists and pathologists a new option...
The kit is optimized for challenging NGS applications including liquid biopsy, somatic variant testing and genome-wide association studies.
The new automation friendly reagents allow laboratories testing for COVID-19 have a tool that allows them to skip the RNA extraction step of the many testing workflows and move directly to PCR amplification.
This new and integrated bioinformatics package provides a comprehensive, private, cloud-based data platform that allows customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.
The kit enables rapid identification of microorganisms from positive blood culture bottles. Harvested microorganisms are processed, and then identified using the MALDI Biotyper CA System.
The new immune Discovery Panel (IDP) consists of 30 different specificities targeting most major immune markers, conveniently grouped together in a single tube. The panel helps enable immune cell type identification and the analysis of their activation and suppression status.
The new IDP consists of 30 different specificities targeting most major immune markers, conveniently grouped together in a single tube.
The IONA Nx uses a new fetal fraction enrichment step with the Yourgene QS250 instrument, which enriches fetal fraction by two-fold, reducing the need for as much sequencing—making it a more cost effective NIPT workflow.
The IVD controls each provide a complete validation for extraction, amplification, and detection within a molecular assay.